NCT00265811 Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery Status COMPLETED Phase PHASE3
NCT00265356 Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases Status COMPLETED Phase PHASE3
NCT00264979 Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases Status TERMINATED Phase NA
NCT00262808 GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE2
NCT00258232 Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00251485 A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00251186 First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients Status TERMINATED Phase PHASE2
NCT00242788 IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure Status COMPLETED Phase PHASE1/PHASE2
NCT00242086 Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases Status COMPLETED Phase NA
NCT00238381 Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer Status COMPLETED Phase PHASE3
NCT00234429 A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT00230399 Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00229567 Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function Status TERMINATED Phase NA
NCT00228189 Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00227747 Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer Status COMPLETED Phase PHASE3
NCT00227734 Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00225641 Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer Status UNKNOWN Phase NA